In addition, ALK-positive ALCL patients respond to ALK-derived HLA-DRB1 (human leukocyte antigen DR beta 1 chain)-restricted peptides suggesting tumor recognition by CD4+ T cells [8]. The gene discussed is ALK; the disease is neoplasm.